Three decades of CKD due to diabetes mellitus type 2 in China, with projections of disease burden from 2022 to 2036: a systematic analysis for the Global Burden of Disease Study 2021
While age-standardized rates for some outcomes may decline, absolute burdens of T2DM-related CKD in China are increasing, driven by population aging. Strengthening healthcare systems, enhancing risk factor screening (e.g. dietary interventions) and improving diabetes management are imperative for prevention and control.
Authors
- Yuping Wu (ORCID: https://orcid.org/0000-0002-7892-1876)
- Xiaoyi Wang (ORCID: https://orcid.org/0000-0003-2833-7695)
- Li Lu (ORCID: https://orcid.org/0000-0002-0060-1725)
- Xiaojun Li (ORCID: https://orcid.org/0000-0002-3355-6529)
- Ru Chen (ORCID: https://orcid.org/0009-0004-7315-8607)
- Yujun He (ORCID: https://orcid.org/0000-0002-2713-6106)
- Jingjing He (ORCID: https://orcid.org/0000-0003-0322-4846)
- Wei Mai
- Minhui Liu
Institutions
- Guangxi Medical University (CN)
- Wenzhou Medical University (CN)
- Tumor Hospital of Guangxi Medical University (CN)
- Zhejiang Taizhou Hospital (CN)
- Taizhou University (CN)
Publication Details
- Journal
- Clinical Kidney Journal
- Published
- 2025-09-01
- DOI
- https://doi.org/10.1093/ckj/sfaf265
- Primary Topic
- Healthcare Systems and Reforms
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Institute for Health Metrics and Evaluation